FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3093874650> ?p ?o ?g. }

• W3093874650 endingPage "1015" @default.
• W3093874650 startingPage "1015" @default.
• W3093874650 abstract "The conventional top-down, bottom-up and combination approaches of generating drug nanocrystals produce a nanosuspension (NS). It requires significant downstream processing for drying the liquid by suitable means followed by its granulation to develop an oral solid dosage form (OSD). In this paper, we used a novel, spray drying-based NanoCrySP technology for the generation of drug nanocrystals in the form of nanocrystalline solid dispersion (NCSD). We hypothesized that the NCSD would require minimal downstream processing since the nanocrystals are obtained in powder form during spray drying. We further compared downstream processing of NS and NCSD of diclofenac acid (DCF) prepared by wet media milling and NanoCrySP technology, respectively. The NS and NCSD were characterized for crystallinity, crystal size, assay and dissolution. The NCSD was physically mixed with 0.3% Aerosil® 200, 1.76% croscarmellose sodium (CCS) and 0.4% sodium stearyl fumarate (SSF) and filled into size 0 hard gelatin capsules. The NS was first wet granulated using Pearlitol® SD 200 (G1 granules) and Celphere® 203 (G2 granules) in a fluidized bed processor, and the resulting granules were mixed using the same extra granular excipients as NCSD and filled into capsules. A discriminatory dissolution method was developed to monitor changes in dissolution behavior due to crystal growth during processing. Cost analysis and comparison of process efficiency was performed using an innovation radar tool. The NS and NCSD were successfully fabricated with a crystal size of 363 ± 21.87 and 361.61 ± 11.78, respectively. In comparison to NCSD-based capsules (65.13%), the G1 and G2 granules showed crystal growth and decrease in dissolution to 52.68% and 48.37%, respectively, in 120 min. The overall cost for downstream processing of NCSD was up to 80% lower than that of NS. An innovation radar tool also concluded that the one-step NanoCrySP technology was more efficient and required less downstream processing than the two-step wet media milling approach for conversion of nanocrystals to OSD." @default.
• W3093874650 created "2020-10-29" @default.
• W3093874650 creator A5014644932 @default.
• W3093874650 creator A5057003531 @default.
• W3093874650 creator A5087544485 @default.
• W3093874650 date "2020-10-23" @default.
• W3093874650 modified "2023-10-03" @default.
• W3093874650 title "Comparison of Downstream Processing of Nanocrystalline Solid Dispersion and Nanosuspension of Diclofenac Acid to Develop Solid Oral Dosage Form" @default.
• W3093874650 cites W1257189789 @default.
• W3093874650 cites W1264540065 @default.
• W3093874650 cites W1485046279 @default.
• W3093874650 cites W1505631108 @default.
• W3093874650 cites W1590784435 @default.
• W3093874650 cites W1599185368 @default.
• W3093874650 cites W1964085724 @default.
• W3093874650 cites W1972646815 @default.
• W3093874650 cites W1981985195 @default.
• W3093874650 cites W1983162648 @default.
• W3093874650 cites W1983661035 @default.
• W3093874650 cites W1987568924 @default.
• W3093874650 cites W1996073950 @default.
• W3093874650 cites W2000699582 @default.
• W3093874650 cites W2000924336 @default.
• W3093874650 cites W2003192668 @default.
• W3093874650 cites W2006227082 @default.
• W3093874650 cites W2021992892 @default.
• W3093874650 cites W2022288348 @default.
• W3093874650 cites W2024039121 @default.
• W3093874650 cites W2030275485 @default.
• W3093874650 cites W2033911789 @default.
• W3093874650 cites W2035207651 @default.
• W3093874650 cites W2038526752 @default.
• W3093874650 cites W2047393407 @default.
• W3093874650 cites W2051113552 @default.
• W3093874650 cites W2051502029 @default.
• W3093874650 cites W2054260281 @default.
• W3093874650 cites W2054627976 @default.
• W3093874650 cites W2058552470 @default.
• W3093874650 cites W2058560614 @default.
• W3093874650 cites W2063486629 @default.
• W3093874650 cites W2063606088 @default.
• W3093874650 cites W2068984440 @default.
• W3093874650 cites W2069118567 @default.
• W3093874650 cites W2078426596 @default.
• W3093874650 cites W2099378633 @default.
• W3093874650 cites W2114293661 @default.
• W3093874650 cites W2159895683 @default.
• W3093874650 cites W2163196876 @default.
• W3093874650 cites W2167642476 @default.
• W3093874650 cites W2171531336 @default.
• W3093874650 cites W2285619018 @default.
• W3093874650 cites W2287931807 @default.
• W3093874650 cites W2328305925 @default.
• W3093874650 cites W2328876599 @default.
• W3093874650 cites W2346957939 @default.
• W3093874650 cites W2413552575 @default.
• W3093874650 cites W2894998501 @default.
• W3093874650 cites W2921834634 @default.
• W3093874650 cites W2949076958 @default.
• W3093874650 cites W2979215423 @default.
• W3093874650 cites W3124384824 @default.
• W3093874650 cites W4241124503 @default.
• W3093874650 cites W845143872 @default.
• W3093874650 doi "https://doi.org/10.3390/pharmaceutics12111015" @default.
• W3093874650 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7690810" @default.
• W3093874650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33114128" @default.
• W3093874650 hasPublicationYear "2020" @default.
• W3093874650 type Work @default.
• W3093874650 sameAs 3093874650 @default.
• W3093874650 citedByCount "5" @default.
• W3093874650 countsByYear W30938746502021 @default.
• W3093874650 countsByYear W30938746502022 @default.
• W3093874650 countsByYear W30938746502023 @default.
• W3093874650 crossrefType "journal-article" @default.
• W3093874650 hasAuthorship W3093874650A5014644932 @default.
• W3093874650 hasAuthorship W3093874650A5057003531 @default.
• W3093874650 hasAuthorship W3093874650A5087544485 @default.
• W3093874650 hasBestOaLocation W30938746501 @default.
• W3093874650 hasConcept C127413603 @default.
• W3093874650 hasConcept C140676511 @default.
• W3093874650 hasConcept C159985019 @default.
• W3093874650 hasConcept C171250308 @default.
• W3093874650 hasConcept C175854130 @default.
• W3093874650 hasConcept C178790620 @default.
• W3093874650 hasConcept C185592680 @default.
• W3093874650 hasConcept C192562407 @default.
• W3093874650 hasConcept C203036418 @default.
• W3093874650 hasConcept C2084832 @default.
• W3093874650 hasConcept C2777091354 @default.
• W3093874650 hasConcept C2778572730 @default.
• W3093874650 hasConcept C2779587474 @default.
• W3093874650 hasConcept C2908765736 @default.
• W3093874650 hasConcept C42360764 @default.
• W3093874650 hasConcept C43617362 @default.
• W3093874650 hasConcept C46275449 @default.
• W3093874650 hasConcept C77281830 @default.
• W3093874650 hasConcept C79191725 @default.
• W3093874650 hasConcept C88380143 @default.

• next